Have you heard of GoodRX (ticker symbol: GDRX), a U.S. stock?
It is a company that operates a price comparison app for prescription drugs.
In this article, I will introduce the company’s financial results for the period January to March 2021, which were announced on May 14, 2021.
January to March 2021
EPS is 7¢ vs. 7¢ forecast.
Net sales: $160 million vs. forecast of $160 million.
Sales growth was +20.2% YoY.
Net income was $1.7 million.
Monthly customers were 5.7 million, up 17% from the same period last year. This compares to 4.9 million in the same period last year.
Subscription plan customers increased 96% year-over-year to 931,000. In the same period last year, the number was 475,000.
Operating cash flow was $45.5 million. Cash flow from operations was $45.5 million compared to $45.6 million in the same period last year.